<DOC>
	<DOCNO>NCT00018694</DOCNO>
	<brief_summary>The treatment cerebrotendinous xanthomatosis bear error bile acid synthesis chenodeoxycholic acid . Patients disease produce cholestanol bile acid precursor block synthesis . Replacement chenodeoxycholic acid shut abnormal pathway reduces elevate level cholestanol improve clinical syndrome .</brief_summary>
	<brief_title>Cholestanol Humans</brief_title>
	<detailed_description>Cerebrotendinous xanthomatosis recessively inherit bear bile acid synthesis due mutation sterol 27-hydroxylase ( CYP27A1 ) . Patients disease suffer xanthoma locate brain tendon , accelerate atherosclerosis progression neurologic disease cataract . Plasma cholesterol level normal cholestanol C-27 bile alcohol precursor bile acid synthesis accumulate believe responsible atherosclerosis , xanthoma neurologic disease . Analysis bile reveal severe sufficiency primary bile acid chenodeoxycholic acid produce inherit defect . However , replacement chenodeoxycholic acid enterohepatic pool inhibit abnormal bile acid synthesis reduces elevate level cholestanol C-27 bile alcohol therapy halt neurologic disease prevents symptomatic atherosclerosis developing .</detailed_description>
	<mesh_term>Xanthomatosis</mesh_term>
	<mesh_term>Xanthomatosis , Cerebrotendinous</mesh_term>
	<mesh_term>Chenodeoxycholic Acid</mesh_term>
	<criteria>Patients clinical biochemical finding cerebrotendinous xanthomatosis . Elevated level serum cholestanol bile acid precursor .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>bile acid synthesis</keyword>
	<keyword>chenodeoxycholic acid</keyword>
	<keyword>sterol 27-hydroxylase</keyword>
</DOC>